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Introduction
Despite advances in pain treatment, many patients still report moderate to severe pain after surgery [1] . More insistent therapeutic strategies are sought, including the ability to target patients prone to more pain. Prediction of postoperative pain is still a challenge, although many factors, like age, gender, pain before surgery, psychological aspects, quantitative sensory testing, and pain induced by venous cannulation, have all been shown to be influential [2] [3] [4] . Genetic factors have been proposed to explain interindividual differences in pain sensitivity and intensity [5] . A future goal in clinical settings would be to predict postoperative pain intensity-and risks of persistent pain-from individually determined pain sensitivity before surgery.
Replacement of a nucleotide in less than 1% of a population is called a mutation, and in more than 1% a single nucleotide polymorphism (SNP). A quiet allelic variation, that is, not altering the phenotype at all, may fall outside the coding region or be synonymous (inside the region but not influencing the amino acid sequence). In contrast, a nonsynonymous variation within the coding region may influence the amino acid sequence and affect the phenotype [6] .
Numerous different genes and single nucleotide polymorphisms have been suggested to be involved in pain sensitivity [7] . However, it has been hard to replicate results obtained in gene association studies [8] , and to our knowledge no genetic study on candidate pain genes has been designed by defining the phenotype by both preoperative pain sensitivity and postoperative pain intensity.
We have recently reported that pain intensity induced by peripheral venous cannulation correlates with postoperative pain intensity after laparoscopic cholecystectomy [2] . Blood obtained from those patients was sent for analysis by SNP array to compare SNP variations within potential candidate pain genes between a painsensitive group (cases) and a low-pain group (controls).
The aim of this clinical case-control study was to identify SNPs potentially associated with sensitivity of pain in surgical patients.
Materials and Methods

Study Patients
The study was approved by the regional Human Research Ethics Review Board at Lund University Faculty of Medicine, Lund, Sweden, on September 16, 2010 (Dnr: 2010/391).
A total number of 180 study patients (18-79 years of age, adequate knowledge of Swedish language, no recurrent pain) scheduled for elective laparoscopic cholecystectomy at the county hospitals in Halmstad and Kungsbacka, Sweden, were consecutively included after oral and written informed consents. Out of 31 patients excluded after inclusion, five were lost to follow-up, 11 were converted to open surgery, five were converted to another kind of anesthesia, and 10 had inadequate recordings, leaving 149 study patients for data analysis. Inclusion criteria and anesthetic and surgical techniques have been reported in more detail elsewhere [2] .
Anesthetic Procedures
All study patients were given oral etoricoxib 120 mg, paracetamol 1500 mg (1,000 mg if <50 kg), and slowrelease oxycodone 10 mg (5 mg if >65 years), for preemptive analgesia. Intravenous (iv) ondansetron 8 mg was administered, together with betamethasone 4 mg, to prevent nausea. General anesthesia was induced and maintained by target-controlled intravenous (iv) infusion of short-acting drugs (propofol 3-4 lg/mL and remifentanil 3-8 ng/mL) dosed according to gender, age, and body weight. Ropivacaine 3 mg/kg was used for local infiltration anesthesia in the surgical wound, and morphine 0.2 mg/kg was administered iv 30 minutes before extubation for postoperative analgesia.
Assessments of Pain Intensity
Preoperative pain sensitivity, induced by the insertion of a Venflon (Becton Dickinson, Helsingborg, Sweden) teflon cannula with a 1.1-mm inner diameter on the back of the hand, was scored on a 10.0-cm horizontal visual analog scale (VAS) at 2.0 or fewer VAS units by 70 patients, and at more than 2.0 VAS units by 79 patients (Figure 1 ).
Postoperative pain intensity was scored accordingly at wake-up and at 10, 20, 30, 60, and 90 minutes in the postanesthesia care unit (PACU), and the maximum levels of pain intensity during the initial 90-minute period were used as a measure of postoperative pain. Low pain (<4.0 VAS units) was found in 53 patients, and severe pain (!7.0 VAS units) in 70 patients (Figure 1 ).
Phenotype Classification
We used a composite measure of pain sensitivity by scoring preoperative pain associated with venous cannulation and postoperative pain intensity after surgery. Cases (pain group) reported cannulation-induced pain intensity of more than 2.0 VAS units and high [9] maximal postoperative pain intensity (!7.0 VAS units). Controls (low-pain group) reported cannulation-induced pain intensity of 2.0 or fewer VAS units and low [9] maximal postoperative pain intensity (<4.0 VAS units). The cutoff of preoperative pain sensitivity was chosen as previously reported in the same patient cohort [2] patients grading their pain associated with venous cannulation below or above 2.0 VAS units have different risks of developing postoperative pain [2] .
In total, 33 and 26 patients met study criteria for the case and control groups, respectively, and peripheral whole blood samples were sent for genetic analysis. However, as two blood samples, one from each study group, were lost in this process, genetic information was obtained in 32 case patients and 25 control patients ( Figure 1 ).
Genotype Determination
The blood samples were transferred to the Department of Clinical Pathology and Cytology, Halmstad, Sweden, by permission of the Regional Biobank Centre, Lund, Sweden, for storage at -80 C within two hours of sampling. DNA was extracted to obtain 1,000 ng per sample at a concentration of 50 ng/lL in an ABgene 96 wellplate provided by SciLife Lab, Uppsala, Sweden. Sufficient concentration of DNA was verified by the Pica Green method in all samples.
Genotyping was performed according to the manufacturer's protocol using the HumanOmniExpressExome-8-v1-2-B beadchip, by the SNP and SEQ Technology Platform, Department of Medical Sciences, Molecular Medicine, Biomedical Centre, Uppsala University, Uppsala, Sweden. The total number of analyzed SNP markers was 964,193. The results were analyzed using the software GenomeStudio 2011.1 (Illumina Inc., San Diego, CA, USA) [10, 11] , and quality control was performed using PLINK v. 1.90b3n (http://pngu.mgh.harvard.edu/purcell/plink/) [12] . The assembly version Hg 19 (also known as GRCH 37) was chosen for the analysis.
In the data cleaning process, a check for gender was done as part of quality control. There were discrepancies in two samples, but both of them could be resolved by evaluation of recorded data. We checked for missing genotype rate greater than 2%, minor allele frequency of less than 1%, and sample call rate greater than 2%, and no samples were removed due to mismatch. The total genotyping rate was 0.999365. In total, 472 variants were removed due to deviation from the Hardy-Weinberg equilibrium (threshold P values < 0.001), and 662,348 variants passed filters and quality control.
Candidate Gene Search
Our candidate genes were selected by making a search on PubMed Gene with the search terms "postoperative pain" and "homo sapiens." Thirteen genes were obtained: ABCB1, COMT, PEBP1, CYP2D6, OPRM1, CYP34A, POMC, MAOB, SCN9A, UGT2B7, SUDS3, TAOK3, and VSIG10. Functions of, and comments on, the genes are summarized in Table 1 .
Statistics
Data were analyzed with PLINK v. 1.90b3n and IBM SPSS 23.0 (IBM Inc., Armonk, NY, USA) software. Associations between SNPs and the pain phenotypes were tested with linear regression analysis. To correct for multiple testing, we used the permutation option of PLINK to obtain adjusted P values (EMP2) based on 10,000 permutations for each SNP. Levels of pain intensity were analyzed with nonparametric statistics and reported as median with interquartile range (IQR). For 
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proportions, 95% confidence intervals (CIs) are reported. Continuous variables like age and body weight were compared between groups with the Mann-Whitney U test, and categorical variables like gender were compared with the Pearson chi-square test. Statistical significance was set at a P value of less than 0.05.
Results
Patients in the case (pain) group were significantly younger (P < 0.001), had lower body weight (P < 0.01), and were more often women (P < 0.05) than in the control (low-pain) group. Their median pain intensity associated with venous cannulation was 3.4 VAS units compared with 1.0 VAS units in the control group, and their median maximum postoperative pain intensity was 8.0 VAS units compared with 1.5 VAS units in control patients ( Table 2) .
Out of 662,348 variants from the SNP array, 446 markers were identified in the 13 genes chosen as candidate genes. The 10 most significant ones are listed in Table 3 . None of them reached the recommended threshold level (5Â10 À8 ) for genome-wide statistical significance [13] on Bonferroni correction for multiple testing (P ¼ 0.00012) or permutation testing.
As proposed by others [14] , we chose a small number of SNPs with low P values for further visual graphical analysis (Figure 2) . The minor alleles of these SNPs in the ABCB1 gene suggest a pain-sensitive phenotype both pre-and postoperatively.
Concerning a few previously well-studied SNPs believed to influence pain sensitivity [7] , rs1045642 (also known as C3435T) in the ABCB1 gene has been well studied. We found no association between this SNP and pain [42]
MAOB
Mono-amine oxidase B
Involved in the development of allodynia in postoperative pain.
[45]
SCN9A
Voltage-gated sodium-channel type IV-a subunit (Nav 1.7)
Sodium channel involved in pain signaling in the dorsal root ganglion and sympathetic neurons.
[ 
sensitivity (odds ratio [OR]
¼ 0.829, P > 0.300). In the COMT gene, rs4680, also referred to as val158met (OR ¼ 0.857, P > 0.300), and rs740603 (OR ¼ 0.68, P > 0.300) did not show significant association with maximum postoperative pain intensity. Carriers of the minor allele of rs887200 reported less pain (OR ¼ 4.98, P values ¼ 0.028), but the results were not statistically significant when adjusted for multiple testing.
Discussion
Results obtained in this hypothesis-generating casecontrol study did not reach statistical significance after correction for multiple testing despite well-defined phenotypes, considerably differing in their reported levels of pain intensity. Nevertheless, specific genetic patterns brought out in these patients suggest specific SNPs to be associated with individual pain responses after surgery, in agreement with previous findings [15, 16] .
In this study, the most common SNPs are all located within ABCB1-an already highly presumed candidate pain gene.
Our statistically most significant SNP (significance lost after correction for multiple testing), rs4728702, has been suggested to be involved in adult antisocial behavior in a genome-wide association analysis study of a cohort with alcohol abuse [17] . Interestingly, the four most significant SNPs in our study (rs4728702, rs1128503, 10276036, rs868755) were all significantly associated with adult antisocial behavior in that study.
The ABCB1 (previously known as MDR1) gene has been implied to be involved in opioid responsiveness [7] . It encodes a drug transporter, part of the ATP binding cassette superfamily efflux transporter, at the capillary endothelial level in the blood-brain barrier and is also involved in opioid transport. Rs1045642 (also known as C3435T) is the most studied SNP in this gene. However, we found no association between this SNP and pain sensitivity.
Catechol-O-methyl transferase (COMT) metabolizes dopamine, epinephrine, and norepinephrine to methoxytyramine, metanephrine, and normethanephrine. It influences pain sensitivity by modulating neuronal transmission [18] , and polymorphisms in this gene have been reported to be associated with pain and opioid responsiveness [19] [20] [21] [22] [23] . Most studies have focused on a few SNPs within the gene, with various results. A frequently investigated polymorphism, rs4680 (also referred to as val158met as it codes for substitution of valine to methionine at codon 158), has been reported to be associated with pain sensitivity [24] [25] [26] and with postoperative and cancer-related requirements of opioids [20, 21, 27] , whereas other studies of rs4680 have shown opposite results [15] . In this study, we found no association between this SNP and the pain-sensitive phenotype.
In a large study on experimental and acute postoperative pain in women undergoing surgery for breast cancer [15] , 22 SNPs within the COMT gene were examined. The SNP rs2518824 was among them; however, it did not show significant results. Three SNPs within the COMT gene (rs4646312, rs2239393, rs4818) were associated with postoperative pain intensity during motion, but none of them withstood statistical correction for multiple testing, and the strongest association was between rs887200 and experimental cold pain intensity as minor allele carriers reported less pain [15] . In our study, carriers of the minor allele of rs887200 also reported less pain, but the results were not significant when adjusted for multiple testing, and other SNPs within the COMT gene appeared to be more important. Accordingly [15] , we found no association between rs740603 and maximum postoperative pain intensity, in contrast to a previous report [23] .
Strengths
The phenotype was defined by composite measures including both pre-operative pain sensitivity and postoperative pain, and cases and controls well defined before high-quality genetic testing was performed by people blinded to the phenotypes. Moreover, identical management of DNA samples reduces the risk of genotyping errors and false associations [13] . This study adds new knowledge on acute postoperative pain after laparoscopic cholecystectomy to the field of genetic association studies. In the field of pain variability and genetic associations, there are studies on migraine and other chronic pain disorders and on opioid consumption [28] , but there are no studies based on a composite measure of pain sensitivity.
Weaknesses
We did not use psychometric tests in this study. This would have been particularly interesting as some findings were quite similar to previous data in patients with adult antisocial behavior [17] . Moreover, we did not a priori perform a statistical power analysis for the genetic assays. Such an analysis would most likely have rendered us with a cohort size requiring a multicenter study design.
Nevertheless, the study design-based on well-defined and highly standardized clinical management of patients with respect to premedication, anesthesia, surgery, and early follow-up-might promote hypothesis-generating genetic evaluation despite low numbers of individuals, considering the opposite phenotype patterns regarding reported pain intensity. Exploratory analyses of genetic variations in small groups of patients with similar phenotype characteristics have apparent risks of error. Although the lack of significant findings challenges development of diagnostic tools for pain prediction based on this method, our findings-if reproduced in larger studies-might still be used to identify patients with higher risk of severe postoperative pain.
Conclusions
This candidate gene study in 57 surgical patients, considerably differing in phenotype characteristics with respect to reported high-or low-intensity pain, was unable to identify statistically significant differences in more than 400 SNPs in 13 candidate pain genes evaluated.
Considering the large number of markers analyzed, this study is statistically underpowered, but the results also reflect the complex pathophysiology of pain. They do, however, suggest a possible genetic contribution of single nucleotide polymorphisms within the genes ABCB1 and COMT in individuals with higher levels of pain sensitivity.
The difficulty reproducing genetic pain studies partially results from the highly complex entity of pain and possibly also from a tendency in the early days of genetic studies to almost exclusively publish positive results.
To increase the chance of finding accurate connections, genome-wide association analysis can be used instead of more limited assays, especially now that they have become more readily available and less expensive. But even when comparing well-defined phenotypes, like in this study, finding a polymorphism that survives multiple statistical testing may prove to be difficult, especially considering the complex entity of pain.
